Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Licence renewal of...

    Licence renewal of drug firms: CAG slams FDA

    Written by Ruby Khatun Khatun Published On 2018-03-30T16:58:25+05:30  |  Updated On 30 March 2018 4:58 PM IST
    Licence renewal of drug firms: CAG slams FDA

    Mumbai: The country's apex auditor CAG has slammed the Food and Drug Administration (FDA), an agency of the Maharashtra government, over the shortage of drug inspectors in the department and a host of other issues.


    The Comptroller and Auditor General (CAG), in its report tabled in the state legislature, also noted that only 20 percent Assistant Commissioners (Food) and 18 percent Food Safety Officers (FSOs) were on the rolls as against the requirement assessed by the FDA Commissioner.



    "The Drugs Division offices were functioning by giving additional charge to Assistant Commissioners. Drug inspectors were also given additional charge of Assistant Commissioners. There was a shortfall of 37 percent in the post of Drug Inspectors," the report stated.

    It said the health regulator had failed to cancel the licenses of 1,535 drug selling units whose licenses had expired. A possible sale of drugs by such units pose a risk to public health.


    The CAG report said in some cases renewal of licenses was done without inspecting the premises of drugs selling units.


    Also, there were serious shortfalls in the inspection of Food Business Operators (FBOs), drugs manufacturing and selling units.


    "The shortfall was to the extent of 35 percent in the case of drugs manufacturing units and 63 percent in case of selling units," the report stated.


    The CAG recommended that the state government conduct a survey and create a database of FBOs which should be updated periodically so as to bring maximum FBOs within the ambit of the Food Safety and Standards Regulations Act.


    The auditor asked the government to address the issue of staff shortage on priority and streamline the procedure of licensing and registration.


    The CAG recommended the government establish additional food testing laboratories to meet the requirements of the entire state and ensure non-functioning ones are made operational with requisite equipment, infrastructure, and manpower.

    CAGComptroller and Auditor Generaldrug firmsdrug inspectorsFDAFood and Drug AdministrationFood Safety and Standards Regulations Actgovernmentlicencelicensingmaharashtraregistrationrenewalshortageslamsstaff shortage
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok